MarketPeel
Insider Trading Intelligence
Pricing
…
DM

Deborah M. Messemer

ALLO
DIRECTOR · ALLOGENE THERAPEUTICS, INC. · CIK 0001754424
FILING MIX · LIFETIME63%/37%
BUYS
19
SELLS
11
TOTAL VALUE
$1.42M
COMPANIES
3
ACTIVE SINCE
May 2020
HOLDINGS NOW
132,458
AVG SELL PX
$11.99
TRADE KIND
SHOWING 30 / 30
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Deborah M. Messemer, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+45.45%-2.23%-0.06%-2.17%+2.58%—
14d11+45.45%-1.37%+0.05%-1.42%+0.69%—
30d11+36.36%+0.40%+1.15%-0.75%+0.15%—
60d11+54.55%-4.36%+1.21%-5.57%-8.07%—
90d11+54.55%-1.38%+2.93%-4.31%-4.83%—
180d11+63.64%-4.78%+9.75%-14.52%-18.95%—
1y11(1 pending)+50.00%-7.83%+17.17%-25.00%-23.69%—
2y11(7 pending)+100.00%-23.23%+39.81%-63.05%-59.16%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ALLO · 95,400 shares · as of Jun 18, 2026
046,35292,703139,055185,406202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 11 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
95,400——95,400Jun 18, 2026Jun 23, 2026 ↗View →
PYPL
PAYPAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
6,275——20,251May 19, 2026May 20, 2026 ↗View →
TPG
TPG INC.
SALE10b5-1
10b5-1 plan
1,796$56.32$101.1K16,807Jul 16, 2025Jul 17, 2025 ↗View →
TPG
TPG INC.
PURCHASEGRANT
Stock grant
2,762——18,603Jul 15, 2025Jul 17, 2025 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
95,400——95,400Jun 18, 2025Jun 20, 2025 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
36,885$1.42$52.4K107,431Jun 10, 2025Jun 12, 2025 ↗View →
PYPL
PAYPAL HOLDINGS, INC.
SALE
3,795$73.00$277.0K13,976Jun 6, 2025Jun 6, 2025 ↗View →
PYPL
PAYPAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
3,795——17,771Jun 5, 2025Jun 6, 2025 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
13,313$2.43$32.4K144,316Feb 18, 2025Feb 20, 2025 ↗View →
TPG
TPG INC.
SALE
1,695$61.91$104.9K15,841Jan 14, 2025Jan 15, 2025 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,136$2.18$19.9K157,629Dec 9, 2024Dec 10, 2024 ↗View →
TPG
TPG INC.
SALE10b5-1
10b5-1 plan
4,089$46.55$190.3K17,536Jul 17, 2024Jul 17, 2024 ↗View →
TPG
TPG INC.
PURCHASEGRANT
Stock grant
3,592——21,625Jul 15, 2024Jul 17, 2024 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
18,641$2.28$42.5K166,765Jun 18, 2024Jun 20, 2024 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
122,950——185,406Jun 5, 2024Jun 7, 2024 ↗View →
PYPL
PAYPAL HOLDINGS, INC.
SALE
4,422$61.65$272.6K13,976May 24, 2024May 24, 2024 ↗View →
PYPL
PAYPAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
4,422——18,398May 22, 2024May 23, 2024 ↗View →
TPG
TPG INC.
SALE
6,390$43.97$281.0K18,033Feb 28, 2024Mar 1, 2024 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
18,640$2.70$50.3K62,456Dec 18, 2023Dec 20, 2023 ↗View →
TPG
TPG INC.
PURCHASEGRANT
Stock grant
5,111——24,423Jul 15, 2023Jul 18, 2023 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
74,561——81,096Jun 13, 2023Jun 15, 2023 ↗View →
PYPL
PAYPAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
4,450——13,976May 24, 2023May 26, 2023 ↗View →
TPG
TPG INC.
PURCHASEGRANT
Stock grant
9,142——19,312Jul 15, 2022Jul 19, 2022 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
71,070——71,070Jun 15, 2022Jun 17, 2022 ↗View →
PYPL
PAYPAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
3,114——9,526Jun 2, 2022Jun 3, 2022 ↗View →
TPG
TPG INC.
PURCHASEGRANT
Stock grant
10,170——10,170Jan 13, 2022Jan 13, 2022 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,015——28,015Jun 10, 2021Jun 11, 2021 ↗View →
PYPL
PAYPAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,053——6,412May 26, 2021May 27, 2021 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,640——16,640Jun 5, 2020Jun 9, 2020 ↗View →
PYPL
PAYPAL HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,856——5,359May 21, 2020May 21, 2020 ↗View →
Other insiders · ALLO
Loading peer insiders…
About this filer
CIK 0001754424
ROLE
Director
PRIMARY
ALLO
COMPANIES
3
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001754424DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback